ePT--the Electronic Newsletter of Pharmaceutical Technology, Nov 24, 2010 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
ePT--the Electronic Newsletter of Pharmaceutical Technology, Nov 24, 2010
News
EMA Committee Makes Decisions on Opioids, Follow-on Biologics
By Angie Drakulich
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) issued on November 19 a summary of its latest meeting.
Novartis to Seek Innovation and Efficiencies
By Erik Greb
On Nov. 17, 2010, Novartis (Basel) disclosed its long-term business strategy, which emphasizes diversification in what the company described as high-growth healthcare segments.
Bayer Announces Restructuring, Increased Focus in Healthcare Business
By Patricia Van Arnum
Bayer (Leverkusen, Germany) announced last week a restructuring program and a strategy to strengthen its focus in research, development, and marketing of new products in its healthcare and crop-sciences businesses as well an interest in expanding its activities in emerging markets.
Week of Nov. 22, 2010: Company and People Notes: Genzyme Sells Business Unit to Sekisui Chemical; Ablexis Names VP of Research; and More.
Genzyme Sells Business Unit to Sekisui Chemical; Ablexis Names VP of Research; and More.
Regulatory Roundup: FDA Issues Statement for Consumers about Antibiotic Use
FDA Issues Statement for Consumers about Antibiotic Use

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
21%
To all process for new products only
13%
To select process for new products only
26%
To select processes for both new and legacy products
21%
Do not use QbD
21%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here